PODCAST

Pulmonary Medicine

ReachMD

science & medicine medicine

All Episodes

00:00:00

New and Emerging PAH Therapies and Approaches: A...

Pulmonary Medicine ·

2025/07/03

Guest: Vallerie V. McLaughlin, MD Guest: Ioana Preston, MD Guest: Kelly Chin, MD, MSCA Pulmonary arterial hypertension (PAH) is a serious, progressive condition that involves making the correct diagnosis and identifying patient comorbidities as important first steps to creating a successful treatment approach. And while identifying which WHO Group a patient belongs to is key, part of the art of treating PAH is recognizing that many patients can have overlap between groups. Our

00:00:00

PH Management in Unique Patients and Conditions

Pulmonary Medicine ·

2025/07/03

Guest: Martha Kingman, DNP, FNP-C Guest: Ioana Preston, MD Guest: Jean M. Elwing, MD Pulmonary arterial hypertension (PAH) is a serious, progressive condition and successfully managing patients can present certain challenges. Treatment selection is multifactorial and often involves the consideration of myriad patient factors, including WHO Group, objective risk stratification score, cardiac functioning on imaging, and shared decision-making. And while all patients who are

00:00:00

Investigating At-Home Subcutaneous Atezolizumab for...

Pulmonary Medicine ·

2025/06/03

Guest: Jorge Nivea, MD Can the immune checkpoint inhibitor atezolizumab be safely administered subcutaneously at home for patients with non-small cell lung cancer (NSCLC)? That’s the exact question an ongoing study is seeking to answer, and here to discuss the study’s objective, design, and potential implications for home-based subcutaneous cancer therapies is Dr. Jorge Nivea. He’s an Associate Professor of Clinical Medicine at the University of Southern California’s Keck School of

00:00:00

Evolving Strategies in Limited-Stage Small Cell Lung...

Pulmonary Medicine ·

2025/05/23

Host: Gerard A. Silvestri MD, MS, Master FCCP Guest: Anurag Singh, MD Guest: Adam H. Fox, MD, MSc Guest: Mariam Alexander, MD, PhD Recent therapeutic advances are reshaping our approach to limited-stage small cell lung cancer. In this multidisciplinary discussion, Dr. Gerard Silvestri sits down with Drs. Adam Fox, Mariam Alexander, and Anurag Singh to explore the evolving standard of care and practical considerations for timely and effective care. Dr. Silvestri is a

00:00:00

Understanding Extensive-Stage Small Cell Lung Cancer:...

Pulmonary Medicine ·

2025/05/23

Host: Gerard A. Silvestri MD, MS, Master FCCP Guest: Anurag Singh, MD Guest: Adam H. Fox, MD, MSc Guest: Mariam Alexander, MD, PhD Despite the typically poor prognosis of extensive-stage small cell lung cancer, recent advancements are reshaping clinical perspectives on treatment. New and emerging options show promise for prolonged survival and improved quality of life. Join Drs. Gerard Silvestri, Adam Fox, Mariam Alexander, and Anurag Singh as they discuss how the

00:00:00

Evaluating High- vs. Low-Dose Corticosteroids in...

Pulmonary Medicine ·

2025/05/20

Guest: Divya Shankar, MD A recent study investigated whether pulse-dose corticosteroids offer a benefit over lower doses in managing acute exacerbations of idiopathic pulmonary fibrosis (IPF). Join Dr. Divya Shankar as she explains the real-world data, variability in prescribing patterns, and outcomes observed in different levels of care. Divya Shankar is an Assistant Professor of Medicine at Boston University Chobanian and Avedisian School of Medicine as well as a Pulmonary and

00:00:00

Neoadjuvant Immunotherapy and Radiation Boosts...

Pulmonary Medicine ·

2025/03/14

Guest: Nasser Altorki, MD Nasser Altorki, MD, chief of thoracic surgery at NewYork-Presbyterian and Weill Cornell Medicine, shares the results of a first-of-its-kind study evaluating low-dose radiation combined with immunotherapy for neoadjuvant treatment of non-small cell lung cancer (NSCLC) tumors. The dual-therapy treatment of durvalumab in combination with stereotactic body radiation was almost twice as effective at tumor killing compared to durvalumab alone. © 2025

00:00:00

Respiratory Challenges in Neuromuscular Disorders: A...

Pulmonary Medicine ·

2025/02/20

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Jason Ackrivo, MD, MSCE Respiratory complications are fairly common in patients with neuromuscular disorders, and given their vast impacts on a patient’s prognosis and quality of life, it’s critical to proactively detect and monitor any signs of respiratory decline. To learn more about the symptoms, impacts, and diagnosis of respiratory complications in patients with neuromuscular disorders, Dr. Charles Turck speaks with Dr. Jason

00:00:00

Navigating Neuromuscular Diseases: CHEST Guidelines...

Pulmonary Medicine ·

2025/02/20

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Bimaje Akpa, MD Clinical practice guidelines from the American College of Chest Physicians provide recommendations for managing respiratory complications in patients with neuromuscular diseases, which can help inform our evaluation and treatment decisions. Joining Dr. Charles Turck to break down key insights from the CHEST guidelines and their impacts on clinical practice is Dr. Bimaje Akpa. Dr. Akpa is an Assistant Professor of

00:00:00

Respiratory Dysfunction in Neuromuscular Disorders:...

Pulmonary Medicine ·

2025/02/12

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Hank Mayer, MD Patients with neuromuscular conditions often exhibit respiratory symptoms that impact their airway clearance and gas exchange, making it increasingly difficult for them to breathe. However, effective assessment techniques and early intervention can help mitigate the progression of this dysfunction, potentially keeping patients from needing extended recovery time or even inpatient care. Joining Dr. Charles Turck to

00:00:00

CRSwNP: Exploring the Role of Nasal Epithelium and...

Pulmonary Medicine ·

2025/02/03

Guest: Kathleen M. Buchheit, MD Guest: Joseph K. Han, MD Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated with a low quality of life and increased healthcare utilization,1,2 and patients often continue to have severe symptoms despite therapy.3 Understanding the role of underlying inflammatory pathways and epithelial dysfunction may help inform clinical decision making for these patients.3,4 In this program, Dr Kathleen Buchheit and Dr Joseph Han share their

00:00:00

CRSwNP: The Critical Role of the Epithelium and...

Pulmonary Medicine ·

2025/01/21

In this brief video, learn more about growing evidence supporting the key role of airway epithelium dysfunction in driving inflammation in CRSwNP. ©2025 Amgen and AstraZeneca. All rights reserved.US-94728 Last Updated 1/25

00:00:00

Implicit Bias in Uncontrolled Asthma Care: Impacts on...

Pulmonary Medicine ·

2025/01/17

Host: Isaretta Riley, MD, MPH Guest: Nicola A. Hanania, MD, MS, FCCP Guest: Jay Peters, MD A recent study assessing the impact of implicit bias on uncontrolled asthma treatment found that a patient’s identity and socioeconomic status can unintentionally influence a physician’s decision-making, impacting the quality of care. Additionally, a critical gap exists in clinician awareness and implementation of health equity practices, which play a key role in mitigating these

00:00:00

COPD Care: Partnership Between Primary Care and...

Pulmonary Medicine ·

2024/12/16

Host: Megan Conroy, MD, MA(Ed), FCCP Guest: Nathan Falk, MD, MBA, FAAFP Primary care providers can play a pivotal role in a patient’s COPD diagnosis by looking out for signs and symptoms and referring patients to pulmonologists when appropriate. The goal of this activity is to educate clinicians about managing patients with COPD symptoms and facilitating earlier diagnosis. Hear both primary care and pulmonary perspectives on diagnostic strategies. CLINICIANS: To access additional

00:00:00

Applying the First 5 Minutes Concept to COPD Care

Pulmonary Medicine ·

2024/11/19

Host: Angela Birdwell, DO, MA, FCCP Guest: Antonio Anzueto, MD Guest: Susan Corbridge, PhD, APRN, ACNP-BC, FAANP, FCCP, FAAN Although the prevalence of chronic obstructive pulmonary disease (COPD) has decreased in adults aged 18 to 44, it remains elevated in certain patient groups, like women, adults over 65, smokers, and those living in rural areas. This prevalence emphasizes the importance of a patient-centered approach, which is why Dr. Angela Birdwell speaks with Drs

00:00:00

Putting Theory Into Practice: Mastering Management of...

Pulmonary Medicine ·

2024/10/18

Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory

00:00:00

Breathing Through the Burden of COPD

Pulmonary Medicine ·

2024/10/18

00:00:00

Going Beyond Today’s Assessments to Confirm COPD, Are...

Pulmonary Medicine ·

2024/10/18

Guest: Surya Bhatt, MD Host: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory

00:00:00

Insights to Pharmaceutical Approaches in COPD

Pulmonary Medicine ·

2024/10/18

00:00:00

Molecular Mechanisms of COPD

Pulmonary Medicine ·

2024/10/18

242 results

Pulmonary Medicine

All Episodes

Similar Podcasts

Eye On The Sky

Vermont Public

Cienciaes.com

cienciaes.com

This Week in Virology

Vincent Racaniello

Hablando con Científicos - Cienciaes.com

cienciaes.com

The Elective Rotation: A Critical Care Hospital Pharmacy Podcast

Pharmacy Joe